Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med, 1980. 302:123.

Foley KM. The “decriminalization” of cancer pain. IN: Advances in pain research and therapy, vol 11: Drug treatment of cancer pain in a drug oriented society. Hill CS , Fields WS (eds), New York, Raven Press 1989.

Perry S. Heidrich. Management of pain during debridement: A survey of US burn units. Pain, 1982. 13:267.

Robins LN, David DH, Nurco DN. How permanent was Vietnam drug addiction? Am J Public Health, 1974. 64:38.

Inturrisi CE, Umans JG. Meperidine biotransformation and central nervous system toxicity in animals and humans. . IN Foley KM, Inturrissi CE (eds): Advances in pain research and therapy, vol 8: Opioid analgesics in the management of clinical pain, p 143. New York , Raven Press, 1986.

Simopoulos TT, et al. Use of meperidine in patient-controlled analgesia and the development of normeperidine toxic reactions. Archives of Surgery, 2002. 137:84-88.

Bruera E, Brenneis C, Michaud M, et al. Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer, 1988. 62:407-411.

Storey P. Subcutaneous infusion for control of cancer symptoms. J Pain Symptom Manage. 1990. 5:33-41.

Levy, MH. Pharmacologic treatment of cancer pain. New Engl J Med, 1996. 335(15):1124-32.